Literature DB >> 2186907

Tissue distribution of avidin and streptavidin injected to mice. Effect of avidin carbohydrate, streptavidin truncation and exogenous biotin.

B Schechter1, R Silberman, R Arnon, M Wilchek.   

Abstract

Radioionated avidin and streptavidin were characterized for their biodistribution and tissue association in Balb/c mice, in comparison to their interaction with cells in vitro. Binding of avidin to spleen and bone-marrow cells in vitro was up to 20-fold higher than that of streptavidin, but when tested in vivo avidin clearance from blood and tissues was considerably faster than that of streptavidin. Levels of avidin at 24 h after an intravenous injection were below 1% (of the injected dose/mass tissue) in most organs. Non-glycosylated avidin was similar in its biodistribution to native avidin. Native streptavidin exhibited higher and prolonged tissue association with 5-10% levels in lung, liver, spleen, kidney and blood, whereas its truncated form showed low tissue levels (1-3%) but a remarkably high affinity to the kidney (80%). Exogenous biotin did not affect streptavidin distribution in vivo but caused a 2-7-fold increase in the retention of avidin (but not non-glycodylated avidin) in some of the organs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2186907     DOI: 10.1111/j.1432-1033.1990.tb15493.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  19 in total

1.  Pretargeting of necrotic tumors with biotinylated hypericin using 123I-labeled avidin: evaluation of a two-step strategy.

Authors:  Thierry Marysael; Matthias Bauwens; Yicheng Ni; Guy Bormans; Jef Rozenski; Peter de Witte
Journal:  Invest New Drugs       Date:  2011-12-21       Impact factor: 3.850

2.  Improved pretargeted delivery of radiolabelled hapten to human tumour xenograft in mice by avidin chase of circulating bispecific antibody.

Authors:  Eric Mirallié; Catherine Saï-Maurel; Alain Faivre-Chauvet; Nicolas Regenet; Chien-Hsing Chang; David M Goldenberg; Jean-François Chatal; Jacques Barbet; Philippe Thedrez
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04-30       Impact factor: 9.236

3.  Optimization of RGD-Containing Cyclic Peptides against αvβ3 Integrin.

Authors:  Yan Wang; Wenwu Xiao; Yonghong Zhang; Leah Meza; Harry Tseng; Yoshikazu Takada; James B Ames; Kit S Lam
Journal:  Mol Cancer Ther       Date:  2015-12-30       Impact factor: 6.261

4.  Tumor-specific detection of an optically targeted antibody combined with a quencher-conjugated neutravidin "quencher-chaser": a dual "quench and chase" strategy to improve target to nontarget ratios for molecular imaging of cancer.

Authors:  Mikako Ogawa; Nobuyuki Kosaka; Peter L Choyke; Hisataka Kobayashi
Journal:  Bioconjug Chem       Date:  2009-01       Impact factor: 4.774

5.  Efficient production of active chicken avidin using a bacterial signal peptide in Escherichia coli.

Authors:  Vesa P Hytönen; Olli H Laitinen; Tomi T Airenne; Heidi Kidron; Niko J Meltola; Eevaleena J Porkka; Jarno Hörhä; Tiina Paldanius; Juha A E Määttä; Henri R Nordlund; Mark S Johnson; Tiina A Salminen; Kari J Airenne; Seppo Ylä-Herttuala; Markku S Kulomaa
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

6.  OXavidin for tissue targeting biotinylated therapeutics.

Authors:  Rita De Santis; Claudio Albertoni; Antonio Rosi; Barbara Leoni; Fiorella Petronzelli; Valeria D'Alessio; Eleonora Nucera; Giovanni Salvatori; Giovanni Paganelli; Antonio Verdoliva; Paolo Carminati; Carlo Antonio Nuzzolo
Journal:  J Biomed Biotechnol       Date:  2010-01-10

Review 7.  Paramagnetic and fluorescent liposomes for target-specific imaging and therapy of tumor angiogenesis.

Authors:  Gustav J Strijkers; Ewelina Kluza; Geralda A F Van Tilborg; Daisy W J van der Schaft; Arjan W Griffioen; Willem J M Mulder; Klaas Nicolay
Journal:  Angiogenesis       Date:  2010-06       Impact factor: 9.596

8.  Improved magnetic resonance molecular imaging of tumor angiogenesis by avidin-induced clearance of nonbound bimodal liposomes.

Authors:  Geralda A F van Tilborg; Willem J M Mulder; Daisy W J van der Schaft; Chris P M Reutelingsperger; Arjan W Griffioen; Gustav J Strijkers; Klaas Nicolay
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

9.  A potential targeting gene vector based on biotinylated polyethyleneimine/avidin bioconjugates.

Authors:  Xuan Zeng; Yun-Xia Sun; Xian-Zheng Zhang; Si-Xue Cheng; Ren-Xi Zhuo
Journal:  Pharm Res       Date:  2009-06-05       Impact factor: 4.200

10.  Structural and functional characteristics of xenavidin, the first frog avidin from Xenopus tropicalis.

Authors:  Juha A E Määttä; Satu H Helppolainen; Vesa P Hytönen; Mark S Johnson; Markku S Kulomaa; Tomi T Airenne; Henri R Nordlund
Journal:  BMC Struct Biol       Date:  2009-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.